Summarecon Agung Tbk PT
IDX:SMRA
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Realty Income Corp
NYSE:O
|
Real Estate
|
| US |
|
Walt Disney Co
NYSE:DIS
|
Media
|
| US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
Technology
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
480
705
|
| Price Target |
|
We'll email you a reminder when the closing price reaches IDR.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
Abbvie Inc
NYSE:ABBV
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Realty Income Corp
NYSE:O
|
US |
|
|
Walt Disney Co
NYSE:DIS
|
US |
|
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
This alert will be permanently deleted.
Summarecon Agung Tbk PT
Summarecon Agung Tbk PT
Cash & Cash Equivalents
Summarecon Agung Tbk PT
Cash & Cash Equivalents Peer Comparison
BSDE
CTRA
RISE
MKPI
Competitive Cash & Cash Equivalents Analysis
Latest Figures & CAGR of Competitors
| Company | Cash & Cash Equivalents | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Summarecon Agung Tbk PT
IDX:SMRA
|
Cash & Cash Equivalents
Rp3.4T
|
CAGR 3-Years
21%
|
CAGR 5-Years
18%
|
CAGR 10-Years
5%
|
|
|
Bumi Serpong Damai Tbk PT
IDX:BSDE
|
Cash & Cash Equivalents
Rp9.4T
|
CAGR 3-Years
7%
|
CAGR 5-Years
7%
|
CAGR 10-Years
9%
|
|
|
Ciputra Development Tbk PT
IDX:CTRA
|
Cash & Cash Equivalents
Rp11.4T
|
CAGR 3-Years
73%
|
CAGR 5-Years
58%
|
CAGR 10-Years
14%
|
|
J
|
Jaya Real Property Tbk PT
IDX:JRPT
|
Cash & Cash Equivalents
Rp647.1B
|
CAGR 3-Years
130%
|
CAGR 5-Years
69%
|
CAGR 10-Years
37%
|
|
|
Jaya Sukses Makmur Sentosa Tbk PT
IDX:RISE
|
Cash & Cash Equivalents
Rp240.4B
|
CAGR 3-Years
105%
|
CAGR 5-Years
27%
|
CAGR 10-Years
N/A
|
|
|
Metropolitan Kentjana Tbk PT
IDX:MKPI
|
Cash & Cash Equivalents
Rp2T
|
CAGR 3-Years
340%
|
CAGR 5-Years
156%
|
CAGR 10-Years
57%
|
See Also
What is Summarecon Agung Tbk PT's Cash & Cash Equivalents?
Cash & Cash Equivalents
3.4T
IDR
Based on the financial report for Mar 31, 2024, Summarecon Agung Tbk PT's Cash & Cash Equivalents amounts to 3.4T IDR.
What is Summarecon Agung Tbk PT's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 10Y
5%
Over the last year, the Cash & Cash Equivalents growth was 4%. The average annual Cash & Cash Equivalents growth rates for Summarecon Agung Tbk PT have been 21% over the past three years , 18% over the past five years , and 5% over the past ten years .
You don't have any saved screeners yet
